Opinion: Reformulating drugs helps profits more than patients
Prescription drug prices remain stubbornly high in the U.S. even though making drugs more affordable…
Author: STAT
Opinion: Medical schools need to be part of the solution to preventing gun violence
Like so many Americans, we watched in horror the news reports about the mass shootings…
Three burning questions about the first brain reference charts
Scientists have created the first reference charts for the human brain, mapping its growth from…
U.S. Covid test makers anticipate layoffs after government reallocates funds
Domestic Covid test manufacturers are wrestling with the federal government’s decision to shuttle an already…
Life expectancy for Native Americans has stagnated — even long before Covid
Native American and Alaska Native populations were the only Americans to see no increase whatsoever…
STAT+: FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes
In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on…
Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer’s setback
Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can…
Hospital data is funneled to Facebook, Verily’s business model, and virtual reality surgery
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Romney accuses White House of ‘patently false’ information about Covid-19 funds
WASHINGTON — Mitt Romney, a prominent Republican senator who spearheaded failed Covid-19 response funding negotiations, on…
.jpg)
STAT+: Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results
Hello, everyone, and how are you today? Another dank cloudy cover greeted us this morning,…
STAT+: A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease
Roche reported negative results Thursday from a long-running clinical trial investigating an experimental antibody treatment…
STAT+: Facebook is receiving sensitive medical information from hospital websites
A tracking tool installed on many hospitals’ websites has been collecting patients’ sensitive health information…
Opinion: New report: gains in patient safety have stalled over the past decade
Hospital care helps patients recover from serious illness and injury but, all too often, patients…
Girl’s case of lupus leads to new understanding of a perplexing disease
As a young girl, Gabriela Piqueras wasn’t quite like the other children in her class….
STAT+: Verily co-founder lays out vision for how real-world data can transform health care
SAN DIEGO — The real world’s a messy place, but there’s a lot you can…
STAT+: A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
The conversation reflected frustration and disbelief. A woman had called SilverScript, which runs one of…
Opinion: Technology is expanding virtual access to health care. Here’s how to ensure equitable outcomes
Virtual health capabilities are evolving far beyond video consultations with a doctor. They now encompass…
FDA panel votes unanimously that Pfizer and Moderna shots be authorized for young children
For an archived version of a live blog about Wednesday’s FDA advisory panel hearing, click…
Popular drug may have new benefit in men with diabetes, but not women, study shows
A new study finds that a popular erectile dysfunction drug, which is increasingly being used…
.jpg)
STAT+: Supreme Court sides with hospitals on Medicare drug pay dispute
WASHINGTON — The Supreme Court on Wednesday sided with hospitals in a legal dispute over…
STAT+: Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: FDA oversight of pharma manufacturing facilities plunges during the pandemic
Each year, the Food and Drug Administration tracks its progress inspecting pharmaceutical manufacturing facilities and…
STAT+: Third Rock Ventures plots next chapter after raising $1.1 billion fund
Third Rock Ventures has raised $1.1 billion for its largest-ever fund, the biotech venture capital…
Tracking an FDA advisory panel meeting on Covid vaccines in young children
Parents of America, you’re in the home stretch. In all likelihood, Covid-19 vaccines for children…
Opinion: Youth and gender-affirming care: let’s start with ‘do no harm’
No decent person wants to hurt children. Yet as pediatricians and longtime public health practitioners,…
STAT+: Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds
The Blue Cross Blue Shield system of health insurance companies boasts on its website, “We…
STAT+: In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries
In a first-of-its-kind arrangement, Shionogi has reached an agreement with the Global Antibiotic Research and…
STAT+: New Jersey hospitals scrap merger after FTC challenge
Two New Jersey hospital systems have called off their proposed merger less than two weeks…
FDA panel unanimously backs Moderna’s Covid vaccine for children ages 6 to 17
A panel of experts convened by the Food and Drug Administration voted unanimously Tuesday to…
Pfizer’s Paxlovid study fails to answer key questions over benefit for broader populations
Pfizer said Tuesday that a much-watched study of its antiviral Paxlovid in patients who have…
Opinion: IP nationalism: the unexamined issue underlying the controversial WTO vaccine proposal and beyond
Countries that are members of the World Trade Organization are currently considering a watered-down version of…
The Senate health committee finally marks up its user fee bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Newest Omicron Covid-19 lineages gaining ground in United States
We’re still in the Age of Omicron, but the face of it keeps changing. The…
WHO to convene emergency committee on monkeypox spread
The World Health Organization announced Tuesday that it will convene a meeting of outside experts…
Health tech companies are facing a wave of layoffs
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Lawmakers urge FTC to probe blood thinner prices; EU pressures Covid vaccine makers to renegotiate contracts
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Amylyx’s case for approval of its ALS drug isn’t ironclad. Here’s why I think it will still happen
The odds that Amylyx Pharmaceuticals wins approval from the Food and Drug Administration for Albrioza,…
STAT+: A widely anticipated ALS drug wouldn’t be cost effective if priced the same as an older rival
Amid growing demand for ALS treatments, a preliminary analysis finds an experimental medicine that may…
STAT+: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
WASHINGTON — Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether…
Opinion: The irony — and ignominy — of medical conferences as superspreader events
Emergency physicians like us have seen the worst of Covid-19, from children gasping for breath…
Francis Collins on his new life as White House science adviser
WASHINGTON — Francis Collins’ 2022 hasn’t exactly gone according to plan. The mustachioed, Harley-riding geneticist…
STAT+: The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it
After the Federal Trade Commission’s flashy announcements last week that it was suing to block…
Enrollment in medical cannabis programs saw four-fold increase, study finds
Enrollment in medical cannabis programs across the U.S. jumped by over four times between 2016…
STAT+: FDA approved more cancer drugs than EMA, but they may not have always benefited patients
Amid rising pressure to endorse new medicines, U.S. regulators greatly outpaced their European counterpart in…
Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity
The Food and Drug Administration on Monday approved an Eli Lilly drug that is the…
Opinion: Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers
This week, when the CDC’s vaccine advisory committee considers approving the Moderna and Pfizer/BioNTech mRNA…
STAT+: In early trial, drug shrinks tumors in majority of children with most common form of brain cancer
Day One Biopharmaceuticals reported Sunday that an experimental molecule shrank tumors by at least 50%…
Rune Labs’ Apple Watch tracking for Parkinson’s earns FDA greenlight
Software that enables Apple Watch-based tracking of Parkinson’s disease symptoms has received clearance from the…
Language barriers keep parents from asking questions about their children’s care, study finds
Handoffs are one of the most dangerous times in a patient’s care: As one team…
STAT+: Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…